Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Lang

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Urologic Oncology|July 14, 2019
Understanding dynamic interactions in the prostate tumor microenvironmentJoshua M Lang
Cancer|December 25, 2018
Are liquid biopsies ready for primetime?Hamid Emamekhoo, Joshua M Lang
Urologic Oncology|November 22, 2018
Development and translation of novel therapeutics targeting tumor-associated macrophagesDavid Kosoff, Joshua M Lang
Methods (San Diego, Calif.)|November 19, 2013
Editorial for "methods for the isolation and analysis of rare cells"David J Beebe, Joshua M Lang
Clinical Medicine Insights. Oncology|October 29, 2010
Pazopanib for the treatment of patients with advanced renal cell carcinomaJoshua M Lang, Michael R Harrison
Immunotherapy|November 6, 2013
Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapiesDavid Kosoff, Timothy Krueger, Joshua M Lang
The Journal of Urology|February 13, 2019
Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial ApproachesShivashankar Damodaran, Joshua M Lang, David F Jarrard
Lab on a Chip|November 6, 2013
Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirementsJonathan D King, Benjamin P Casavant, Joshua M Lang
Lab on a Chip|December 13, 2021
Volumeless reagent delivery: a liquid handling method for adding reagents to microscale droplets without increasing volumeDuane S Juang, Joshua M Lang, David J Beebe
Expert Review of Vaccines|December 1, 2009
Prioritization of cancer antigens: keeping the target in sightJoshua M Lang, Adin-Cristian Andrei, Douglas G McNeel
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Urologic Oncology|July 14, 2019
Understanding dynamic interactions in the prostate tumor microenvironmentJoshua M Lang
Cancer|December 25, 2018
Are liquid biopsies ready for primetime?Hamid Emamekhoo, Joshua M Lang
Urologic Oncology|November 22, 2018
Development and translation of novel therapeutics targeting tumor-associated macrophagesDavid Kosoff, Joshua M Lang
Methods (San Diego, Calif.)|November 19, 2013
Editorial for "methods for the isolation and analysis of rare cells"David J Beebe, Joshua M Lang
Clinical Medicine Insights. Oncology|October 29, 2010
Pazopanib for the treatment of patients with advanced renal cell carcinomaJoshua M Lang, Michael R Harrison
Immunotherapy|November 6, 2013
Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapiesDavid Kosoff, Timothy Krueger, Joshua M Lang
The Journal of Urology|February 13, 2019
Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial ApproachesShivashankar Damodaran, Joshua M Lang, David F Jarrard
Lab on a Chip|November 6, 2013
Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirementsJonathan D King, Benjamin P Casavant, Joshua M Lang
Lab on a Chip|December 13, 2021
Volumeless reagent delivery: a liquid handling method for adding reagents to microscale droplets without increasing volumeDuane S Juang, Joshua M Lang, David J Beebe
Expert Review of Vaccines|December 1, 2009
Prioritization of cancer antigens: keeping the target in sightJoshua M Lang, Adin-Cristian Andrei, Douglas G McNeel
Pageof 11